Airiver Medical Secures IDE Approval from the FDA for Pivotal Clinical Study of the Airiver Drug Coated Balloon for Patients with Chronic Rhinosinusitis
The nationwide study will assess the safety and efficacy of the technology that combines standard balloon dilation to open the nasal passageways with drug delivery designed to maintain symptom relief
MASS DEVICE: Airiver Medical Wins FDA IDE for Pulmonary Drug-Coated Balloon
Airiver Medical Receives IDE Approval from the FDA for Pivotal Clinical Study of the Airiver Pulmonary Drug Coated Balloon to Treat Benign Central Airway Stenosis
The nationwide study will assess the safety and efficacy of the technology that combines standard balloon dilation to open the nasal passageways with drug delivery designed to maintain symptom relief